	Beneficio Bruto En Ventas		Fecha
Akebia Therapeutics	USD 49.21M	13.25M	2025-03
Alaunos Therapeutics	USD -1.13M	1.11M	2024-09
Avita Medical	AUD 14.31M	639K	2025-12
Celltrion	KRW 626.11B	81.75B	2025-09
Cspc Pharmaceutical	CNY 4.34B	333.68M	2025-09
Deva Holding AS	TRY 1.32B	235.77M	2023-09
Dianthus Therapeutics	USD 396K	203K	2025-09
Divis Laboratories Ltd	INR 16.59B	2.05B	2025-12
IQVIA Holdings	USD 1.12B	32M	2025-12
Kangmei Pharma	CNY 270.29M	20.26M	2025-09
Knight Therapeutics	CAD 44.83M	9.96M	2025-06
Laboratorios Farma	EUR 105.28M	177.08M	2025-06
Medical Developments International	AUD 7.35M	7.37M	2025-06
Moderna	USD 226M	583M	2025-12
Neuren Pharmaceuticals	AUD 6.69M	6.37M	2025-06
Organigram Holdings	CAD 31.84M	23.88M	2025-09
Organon & Co	USD 854M	3M	2025-12
Pharma Mar	EUR 33.36M	20.25M	2025-09
Qiagen NV	USD 325.27M	19.53M	2025-12
Revvity	USD 421.66M	47.06M	2025-12
Sartorius	EUR 393.2M	23M	2025-09
Sino Biopharmaceutical	CNY 10.5B	2.53B	2024-12
Tectonic Therapeutic	USD 0	0	2025-03
Tilray	USD 67.63M	15.62M	2025-03
Viatris	USD 1.15B	223.6M	2025-12
Xeris Pharmaceuticals	USD 63.38M	3.74M	2025-09
Zz Pientze Pharmaceu	CNY 296.13M	1.1B	2025-06

Dianthus Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.